Assertio Therapeutics

Assertio Therapeutics(ASRT)

Assertio Therapeutics, Inc. (formerly Depomed, Inc.) is an American specialty pharmaceutical company. It mainly markets products for treatment in neurology, pain and diseases of the central nervous system. Depomed was founded in 1995 and is headquartered in Newark, California. It is a publicly traded company on NASDAQ, with several products approved by the United States Food and Drug Administration (FDA). On August 15, 2018, the company announced its name change from Depomed, Inc., to Assertio Therapeutics, Inc. As of 2019, Assertio markets three products approved by the FDA: Gralise, Cambia, and Zipsor.

Download report

Favorite

Financial

Marketed Drugs

Clinical Trials

Financial

Stock price

*Currency in USD

Company Revenue

Quarterly

Annual

Projections

*Quarterly sales USD (in millions)

Mock data
Subscribe for the real data

Revenue by Drug

Marketed Drugs

Therapeutic Areas:

All

Classification:

All

Include Generics:

Trade Name	Drug Name	Approved	Patent Expires	Indication
Cambia	Diclofenac potassium	2009-06-17	2026-2035	—
Proquin	Ciprofloxacin	2005-05-19	2025-2038	Neutropenia , Prostatitis , Fever , Urinary tract infections , Sinusitis , Typhoid fever , Diarrhea , Bacterial infections , Gonorrhea , Intraabdominal infections , Pseudomonas infections , Bacterial skin diseases , Osteomyelitis , Escherichia coli infections , Campylobacter infections , Bacterial conjunctivitis , Staphylococcal infections , Infectious arthritis , Pyelonephritis , Proteus infections , Anthrax , Klebsiella infections , Otitis externa , Haemophilus infections , Protozoan infections , Cystitis , Dysentery , Bacteroides infections , Leukemia , Septic shock , Ulcerative colitis , Ankylosing spondylitis , Vomiting , Nausea , Sarcoidosis , Thrombocytopenic purpura idiopathic , Pulmonary tuberculosis , Mycosis fungoides , Systemic lupus erythematosus , Rheumatic diseases , Bursitis , Keratitis , Allergic rhinitis perennial , Thyroiditis , Iritis , Hypercalcemia , Brain edema , Pemphigus , Addison disease , Collagen diseases , Dermatitis herpetiformis , Psoriasis , Atopic dermatitis , Pruritus , Inflammation , Facial dermatoses , Foot dermatoses , Hand dermatoses , Scalp dermatoses , Leg dermatoses , Shock , Pruritus ani , Adrenal insufficiency , Status asthmaticus , Contact dermatitis , Hemorrhoids , Congenital adrenal hyperplasia
Zipsor	Diclofenac potassium	2009-06-16	2026-2035	—